KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Non-Current Deffered Revenue: 2009-2021

Historic Non-Current Deffered Revenue for Dynavax Technologies (DVAX) over the last 7 years, with Dec 2021 value amounting to $5.4 million.

  • Dynavax Technologies' Non-Current Deffered Revenue was N/A to $5.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $5.4 million, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2021, which is N/A change from last year.
  • Dynavax Technologies' Non-Current Deffered Revenue amounted to $5.4 million in Q4 2021, which was down 92.06% from $68.0 million recorded in Q3 2021.
  • Dynavax Technologies' Non-Current Deffered Revenue's 5-year high stood at $107.0 million during Q2 2021, with a 5-year trough of $5.4 million in Q4 2021.
  • For the 1-year period, Dynavax Technologies' Non-Current Deffered Revenue averaged around $61.2 million, with its median value being $66.2 million (2021).